Advertisement

Topics

FDA approves Imbruvica expansion to treat chronic graft versus host disease

13:21 EDT 3 Aug 2017 | Drug Store News

The drug received priority review and breakthrough therapy designations, as well as orphan drug designation for this indication.

read more

Original Article: FDA approves Imbruvica expansion to treat chronic graft versus host disease

NEXT ARTICLE

More From BioPortfolio on "FDA approves Imbruvica expansion to treat chronic graft versus host disease"

Quick Search
Advertisement
 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...